Press release
Migraine Drugs Market Growth Overview Along with Company Profiles Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc.
Migraine Drugs Market
Surge in awareness about migraine treatment and prevention across the globe is anticipated to significantly drive the growth of the migraine drugs market. Furthermore, rise in female population worldwide is the key factor that augments the market growth.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2811
Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, side effects of migraine drugs are expected to limit the market growth. Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for the market growth during the forecast period.
By type, abortive medicines accounted for more than three-fourths share of the global migraine drugs market in 2017. Furthermore, by route of administration, the oral segment is anticipated to grow at the highest rate of 3.4% during the forecast period.
KEY FINDINGS OF THE STUDY
• North America occupied two-fifths share of the global migraine drugs market.
• Oral is anticipated to grow with the highest CAGR throughout the forecast period.
• Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2811
The report provides an extensive competitive analysis and profiles of the key market players such as Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc. The other players in the value chain (not included in the report) include Novartis International AG, Teva Pharmaceutical Industries Limited, and Sanofi SA.
Table Of Content
Chapter: 1: INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.3.1. List of players profiled in the report
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies, 2016-2018
3.2.3. Market share analysis, 2017
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Increase in prevalence of migraine
3.3.1.2. Growth in female population
3.3.1.3. Rise in awareness among patients towards migraine treatment & prevention
3.3.2. Restraints
3.3.2.1. Side effects of migraine drugs
3.3.3. Opportunities
3.3.3.1. Emerging migraine therapies
3.3.3.2. Growth opportunities in the emerging economies
3.3.4. Impact analyses
Access Full Summery @ https://www.alliedmarketresearch.com/press-release/migraine-drugs-market.html
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market Growth Overview Along with Company Profiles Abbott Laboratories, Allergan Plc., AstraZeneca, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Impax Laboratories, Johnson & Johnson, Merck & Co., and Pfizer Inc. here
News-ID: 1716681 • Views: …
More Releases from Allied Market Research
Peanut Oil Market to garner $15,684.70 million by 2032, registering at a CAGR of …
Peanut oil market size was valued at $10,099.80 million in 2022 and is projected to reach $15,684.70 million by 2032, registering a CAGR of 4.6% from 2023 to 2032.
As the cost of living continues to rise, consumer lifestyles are evolving leading to a noticeable trend toward hosting and dining at home rather than going out. This shift is playing a key role in increasing the demand for peanut oil. Peanut…
Global Sandwich Panels Market to Generate $39.16 Billion by 2031: Dana Group, 3A …
According to the report published by Allied Market Research, the global sandwich panels market garnered $20.21 billion in 2021, and is estimated to generate $39.16 billion by 2031, manifesting a CAGR of 6.7% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in…
Brushless DC Motor Market to Reach $72.24 Billion by 2030, Growing at 8.1% CAGR …
Allied Market Research recently published a report, titled, "Brushless DC Motors Market by Rotor type (Inner Rotor, Outer Rotor), by Power range (0-750 W, 751 W- 3 KW, More Than 3 KW), by Speed (Less Than 500 RPM, 501 To 2000 RPM, 2001 To 10,000 RPM, More Than 10,000 RPM), by End user (Industrial Machinery, Automotive, Healthcare, HVAC Industry, Power tools, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030". As…
Service Robotics Market to Reach $293.0 Billion, Globally, by 2032 at 24.3% CAGR …
Allied Market Research published a report, titled, "Service Robotics Market by Type (Professional Service Robotics, and Personal Service Robotics), and Application (Agriculture, Professional Cleaning, Inspection and Maintenance, Construction and Demolition, Transportation and Logistics, Medical, Search, Rescue, And Security, Hospitality, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032.". According to the report, the global service robotics industry generated $21.0 billion in 2020, and is anticipated to generate $293.0 billion by…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
